In the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
Others have stated their priorities directly with Federal Government. Through these interviews, AHJ gives a final opportunity to communicate to all health stakeholders, the funding needs for a range of priorities. These range from new models of care to pilots and wholesale, system improvements to building more sustainable workforces to help grow certain sectors of the health system
The Chief Executive Officer of The Australasian College of Paramedicine, John Bruning spoke with Australian Health Journal about the following:
- New models of care proposed for paramedics
- Paramedicine pilot program in the pre-budget submission
- Scope of how paramedics can support General Practice, and guidelines on safety and quality
- Current limitations experienced by paramedics needing to be addressed by Government
Lastly John talks about other priorities he hopes are included in the Federal Budget. These include a longer term, widespread reform view of the health system. There has been an approach where things have been “added on, gaps filled, issues identified” in 3-4 year cycles. John hopes there is a direction taken where health is completely reformed, including in access for regional, remote and 1st nations people. John sees the public needing further guidance and awareness on the health system to support public health literacy.
Finally cultural training is needed to deliver safe and appropriate health care to the range of diverse populations that clinicians serve. This can lead to fulfilling and purposeful workforce, which in itself needs the Government to consider the wellbeing aspects of clinicians during very challenging times in the pandemic.
You Might also like
-
Using human skin hair follicles to treat Alzheimer’s disease
Professor Michael Valenzuela is a science opinion leader, innovator and creative thinker with a career-long commitment to the prevention and treatment of dementia.
Following that he completed graduate medicine and medical training at the Prince of Wales Hospital. In 2012, he established the Regenerative Neuroscience Group at the University of Sydney, and in 2017 became the university’s first Professor of Regenerative Medicine.
Professor Valenzuela’s group discovered a new cell type with potential for regenerative medicine, a rare neural precursor cell found deep within the human hair follicle. He is the main inventor on several related patents and is the Founder and Chief Scientific Officer of Skin2Neuron – a biotech company developing the first neurorestorative cell therapy for Alzheimer’s disease based on this work.
-
Representing the profession that impacts individual lives and communities
Michelle Oliver is a highly experienced Occupational Therapist with nearly two decades of leadership and clinical expertise across the mental health, homelessness, and disability sectors. She holds a Master of Occupational Therapy from the University of South Australia and is a registered practitioner with AHPRA.
-
A 40-Year Journey: Insights from Tasmania’s Chief Nurse & Midwife
Reflecting on her nursing journey on the Tasmanian Health website on International Nurses Day 2025, Chief Nurse and Midwife, Francine Douce, has seen plenty of change since the start of her nursing and midwifery career, 42 years ago.